I. Cashflow from operating activities
|
|
|
|
|
|
1. Net profit before tax
|
2,155,618
|
726,115
|
1,131,843
|
495,503
|
1,420,329
|
2. Adjustments
|
-1,610,750
|
-57,464
|
-153,647
|
591,683
|
362,996
|
- Depreciation and amortisation
|
253,773
|
265,945
|
268,170
|
343,208
|
321,266
|
- Provisions
|
1,241,932
|
-213,412
|
-191,752
|
-400,724
|
-92,078
|
- Net profit from investment in joint venture
|
0
|
0
|
|
0
|
0
|
- Write off fixed assets
|
0
|
0
|
|
0
|
0
|
- Unrealised foreign exchange profit(loss)
|
1,836
|
-11,443
|
3,465
|
199
|
-2,939
|
- Profit(Loss) from disposals of fixed assets
|
0
|
0
|
|
0
|
0
|
- Profit(Loss) from investing activities
|
-3,363,035
|
-599,292
|
-986,218
|
-160,753
|
-294,732
|
- Profit from deposit
|
0
|
0
|
|
0
|
0
|
- Interest income
|
0
|
0
|
|
0
|
0
|
- Interest expense
|
254,743
|
500,739
|
752,688
|
809,753
|
431,480
|
- Payments direct from profit
|
0
|
0
|
|
0
|
0
|
3. Operating profit before working capital changes
|
544,868
|
668,651
|
978,195
|
1,084,542
|
1,783,325
|
- Increase/decrease in receivables
|
-1,177,046
|
-327,312
|
-237,202
|
2,685,119
|
177,310
|
- Increase/decrease in inventories
|
978,946
|
-1,407,154
|
-2,064,876
|
759,137
|
-551,522
|
- Increase/decrease in payables
|
876,824
|
3,902,710
|
843,752
|
-330,655
|
377,196
|
- Increase/decrease in pre-paid expense
|
30,355
|
2,276
|
-242,342
|
130,542
|
-170
|
- Increase/decrease in current assets
|
0
|
0
|
|
0
|
0
|
- Interest paid
|
-360,198
|
-244,599
|
-811,675
|
-846,023
|
-519,170
|
- Business income tax paid
|
-365,248
|
-308,844
|
-88,502
|
-176,613
|
-157,986
|
- Other receipts from operating activities
|
47,560
|
0
|
|
0
|
0
|
- Other payments from oprerating activities
|
-6,015
|
-9,770
|
-14,201
|
-4,398
|
-1,817
|
Net cashflow from operating activities
|
570,046
|
2,275,957
|
-1,636,850
|
3,301,650
|
1,107,165
|
II. Cashflow from investing activities
|
|
|
|
|
|
1. Purchases of fixed assets
|
-534,142
|
-1,193,130
|
-1,544,074
|
-483,609
|
-20,594
|
2. Proceeds from disposals of fixed assets
|
87,964
|
15,801
|
36,696
|
77,314
|
1,326
|
3. Purchases of debt instruments of other entities
|
-1,908,002
|
-4,456,785
|
-5,714,117
|
-10,606,501
|
-7,356,579
|
4. Proceeds from sales of debt instruments of other entities
|
1,862,353
|
1,658,513
|
8,305,357
|
10,486,908
|
7,296,545
|
5. Payment for investment in joint venture
|
0
|
0
|
|
0
|
0
|
6. Purchases of short-term investment
|
0
|
0
|
|
0
|
0
|
7. Investment in other entities
|
-611,000
|
-7,739,555
|
18,436
|
0
|
-2,500
|
8. Proceeds from disinvestment in other entities
|
3,104,997
|
3,292,310
|
476,956
|
49,637
|
387,645
|
9. Profit from deposit received
|
0
|
0
|
|
0
|
0
|
10. Dividends and interest received
|
161,232
|
450,745
|
361,814
|
234,208
|
251,008
|
11. Purchases of buying minority equity
|
0
|
0
|
|
0
|
0
|
Net cashflow from investing activities
|
2,163,404
|
-7,972,101
|
1,941,068
|
-242,043
|
556,851
|
III. Cashflow from financing activities
|
|
|
|
|
|
1. Proceeds from issue of shares
|
-1,643,648
|
145,307
|
13,077
|
10,210
|
0
|
2. Purchase issued shares from other entities
|
0
|
0
|
|
0
|
0
|
3. Proceeds from borrowings
|
4,256,692
|
13,194,462
|
9,839,688
|
10,113,552
|
8,356,919
|
4. Repayments of borrowing
|
-4,510,220
|
-5,799,218
|
-10,623,325
|
-12,507,175
|
-10,131,857
|
5. Repayments of financial leases
|
0
|
-6,326
|
-5,396
|
-36,651
|
-26,663
|
6. Other purchase from financing activities
|
0
|
0
|
|
0
|
0
|
7. Purchase from capitalization issue
|
0
|
0
|
|
0
|
0
|
8. Dividends paid
|
-143,757
|
-1,089,033
|
-589,175
|
-67,278
|
-71,039
|
9. Minority equity in joint venture
|
0
|
0
|
|
0
|
0
|
10. Social welfare expenses
|
0
|
0
|
|
0
|
0
|
Net cashflow from financing activities
|
-2,040,933
|
6,445,193
|
-1,365,133
|
-2,487,342
|
-1,872,640
|
Net cashflow of the year
|
692,517
|
749,049
|
-1,060,915
|
572,266
|
-208,625
|
Cash and cash equivalents at the beginning of year
|
1,342,791
|
1,995,310
|
2,812,003
|
1,710,245
|
2,669,872
|
Effect of foreign exchange differences
|
0
|
-2,124
|
-1,986
|
-11
|
36
|
Cash and cash equivalents at the end of year
|
2,035,307
|
2,742,235
|
1,749,103
|
2,282,499
|
2,461,283
|